Skip to content
  • About us
    • Overview
    • Our founders
    • Careers
  • Our pipeline
    • Development pipeline
    • Netazepide
      • Background
      • Studies
      • Further studies
    • Ceclazepide
    • TR4
    • TR8
  • Trio Medicines Logo
  • Our publications
  • Contact us
Previous Next

Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.

Lloyd KA, Moore AR, Parsons BN, O’Hara A, Boyce M, Dockray GJ, Varro A and Pritchard DM. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27. Oncotarget 2016; doi 10.18632/oncotarget.9990.

myarzi12019-03-26T13:15:19+00:00Uncategorized|

Share This Story, Choose Your Platform!

FacebookTwitterLinkedInRedditGoogle+TumblrPinterestVkEmail